Hristo Gagov | Hypothesis Fundamentals | Best Researcher Award

Prof Hristo Gagov, Sofia University ‘St. Kliment Ohridski’, Bulgaria

Prof. Hristo Gagov is a distinguished physiologist specializing in Animal and Human Physiology, Pharmacology, and Toxicology 🧬. He earned his MD in Molecular and Functional Biology from Sofia University (1988) 🎓 and a PhD from the Institute of Physiology, Bulgarian Academy of Sciences 🏅. As Head of the “Excitable Cells” Laboratory, his research spans cardiovascular health, ion channels, intracellular signaling, and nanotechnology ⚛️. With 82 publications 📑 and 510 citations, he is a key member of the Bulgarian Physiological Society. His international collaborations include work in Germany and Italy 🇩🇪🇮🇹.

Publication Profile

Orcid

Education

Prof. Hristo Gagov 🎓 earned his MD in Molecular and Functional Biology from Sofia University ‘St. Kliment Ohridski’ in 1988 🏛️. With a passion for physiology and biological sciences 🧬, he pursued a PhD at the Institute of Physiology, Bulgarian Academy of Sciences 🔬. His research contributions span molecular biology, physiological processes, and functional analysis of biological systems 🏥🔍. Through years of dedication to academia and scientific discovery 📚, Prof. Gagov has played a crucial role in advancing knowledge in his field, mentoring future researchers, and contributing to groundbreaking studies in molecular and functional biology 🌍🔎.

Experience

Prof. Hristo Gagov is a distinguished researcher with an impressive academic footprint 📚🔬. He has authored over 82 scientific publications, showcasing his dedication to advancing knowledge. Among these, 68 are indexed with an impact factor, highlighting the high quality and recognition of his work 📑⭐. His research excellence is further reflected in his Scopus H-index of 14, demonstrating the significant influence of his studies in the scientific community 📊🏆. Through rigorous research and impactful contributions, Prof. Gagov continues to shape his field, leaving a lasting mark on global academia 🌍🔎.

Diverse Research Areas

Prof. Hristo Gagov is a distinguished researcher whose expertise bridges multiple disciplines, including cardiovascular physiology ❤️, ion channels 🔬, intracellular signaling ⚡, aging ⏳, nanotechnology 🧪, and electrophysiology 🧠. His interdisciplinary approach has led to significant advancements in understanding cellular mechanisms and their implications for health and disease. With a keen focus on innovation, he explores how nanotechnology can enhance biomedical applications and how ion channels influence physiological functions. His work contributes to the broader scientific community, paving the way for novel therapeutic strategies and deeper insights into aging and cardiovascular health. 🌍📚

Award-Winning

Prof. Hristo Gagov is a distinguished researcher known for his outstanding contributions to scientific projects 🔬📚. His innovative work has earned him prestigious research awards 🏆🎖️, recognizing his dedication and impact in his field. With a commitment to advancing knowledge and fostering scientific excellence, he has played a crucial role in groundbreaking research initiatives 🌍🔍. His achievements highlight his expertise and dedication to pushing the boundaries of discovery 🚀📖. Through his remarkable efforts, Prof. Gagov continues to inspire the academic community, contributing valuable insights and advancements that shape the future of research and innovation 🧠💡.

Research Focus

Prof. Hristo Gagov’s research focuses on molecular physiology, endocrinology, and vascular biology 🧬🩺. His studies explore redox balance in endocrine-related metabolic diseases and cancer 🦠⚖️, emphasizing reductive stress and its pathological effects. He investigates Sirtuin 1’s role in aging and hormonal regulation ⏳🔬, along with the mechanisms of vascular smooth muscle function 💓🩸, particularly in hypertension. Additionally, he examines anticarcinogenic agents like EF24, analyzing their pharmacokinetics, efficacy, and nanoformulation for drug delivery 💊🚀. His interdisciplinary work bridges molecular medicine, aging, and cardiovascular health, contributing to therapeutic advancements 🏥📈.

Publication Top Notes

The Role of Reductive Stress in the Pathogenesis of Endocrine-Related Metabolic Diseases and Cancer

Sirtuin 1 and Hormonal Regulations in Aging

BK Channels in Tail Artery Vascular Smooth Muscle Cells of Normotensive (WKY) and Hypertensive (SHR) Rats Possess Similar Calcium Sensitivity But Different Responses to the Vasodilator Iloprost

Anticarcinogenic Potency of EF24: An Overview of Its Pharmacokinetics, Efficacy, Mechanism of Action, and Nanoformulation for Drug Delivery

Kv2.1 Channels Prevent Vasomotion and Safeguard Myogenic Reactivity in Rat Small Superior Cerebellar Arteries

Andrei Kozlov | Evolutionary Biology | Best Researcher Award

Prof Andrei Kozlov, Vavilov Institute of General Genetics RAS, Russia

Prof. Andrei Kozlov is the Chief of the Lab of Gene Neofunctionalization at the Vavilov Institute of General Genetics RAS and the Director of The Biomedical Center in St. Petersburg, Russia. He also heads the Kozlov Laboratory of Theoretical Biology at Peter the Great St. Petersburg Polytechnic University. Born on May 22, 1950, in St. Petersburg, he earned his M.Sci. in Biochemistry from Leningrad State University and his Ph.D. from the Petrov Research Institute of Oncology. With extensive research in molecular virology and oncology, he has significantly contributed to HIV and cancer research. Prof. Kozlov is married with three children. 📚🔬👨‍👩‍👧‍👦

Publication profile

scopus

Education

In 1972, I earned my M.Sci. in Biochemistry from the Chair of Biochemistry at Leningrad State University, Leningrad, Russia. 🧬 From 1972 to 1975, I pursued my Ph.D. at the Petrov Research Institute of Oncology in St. Petersburg, Russia, focusing on the biochemistry of nucleic acids in both normal and malignant tissues. My Ph.D. thesis was titled “A comparative study of low molecular weight nuclear RNAs in normal and tumor tissues.” 📚 Between 1978 and 1979, I underwent postdoctoral research training in the Lab of Tumor Cell Biology under Dr. R. C. Gallo at the NCI, NIH, Bethesda, MD, USA, specializing in molecular oncovirology. 🔬

Experience

In 1981, I began my career as a Molecular Biology Lecturer at the prestigious Boarding School №45 for especially talented children, attached to St. Petersburg State University. From 1983 to 1987, I lectured on the Biochemistry of nucleic acids at the university’s Department of Biochemistry. I founded and served as Deputy Director of the MPH Program at St. Petersburg State University from 2005 to 2012, where I also lectured on HIV/AIDS Epidemiology & Prevention. Since 2012, I’ve been the Founder and Chief of the St. Petersburg Seminar on Molecular and Evolutionary Biology. Between 2018 and 2019, I was a Professor in the Department of Medical Physics at Peter the Great St. Petersburg Polytechnic University, and since 2019, I have served as a High School Professor at the Institute of Biomedical Systems and Biotechnology. 🌟📚

Honors

From 1992 to 2010, a Fellowship at the International Agency for Research on Cancer (IARC) was the foundation for many notable achievements. During this time, the annual international conference “AIDS, Cancer and Public Health” was established, and 19 conferences were chaired. Notable positions included advisory roles to the Russian parliament on HIV legislation (1994-1995), coordination of the Russian HIV Vaccine Project (1998-2002), and serving on various advisory boards. Numerous awards were received, such as the Russian National Chumakov Award (1999) and the Vernadsky Award (2005). The Vavilov Prize (2020) recognized contributions to cancer and HIV research. 🧬🏅🌍

Research focus

It seems you’re interested in the research focus of A.P. Kozlov. Based on the list of publications provided, Kozlov’s research primarily revolves around the evolutionary and developmental biology (evo-devo) of gene expression, the role of tumors in evolution, and the relationship between normal and tumor-like organs. Kozlov’s work integrates aspects of molecular evolution, gene expression patterns in cancer, and the emergence of novel cell types during evolution. Notably, Kozlov explores the theory of “carcino-evo-devo,” which posits a significant evolutionary role for hereditary tumors. This interdisciplinary approach spans genomics, oncology, and evolutionary biology, shedding light on the complexity of developmental processes and cancer evolution. 🧬🔬🦠📊

Mammalian tumor-like organs. 1. The role of tumor-like normal organs and atypical tumor organs in the evolution of development

Biological Computation and Compatibility Search in the Possibility Space as the Mechanism of Complexity Increase During Progressive Evolution

Erratum: Evolutionarily novel genes are expressed in transgenic fish tumors and their orthologs are involved in development of progressive traits in humans (Infectious Agents and Cancer (2019) 14 (46) DOI: 10.1186/s13027-019-0262-5)

Evolutionarily novel genes are expressed in transgenic fish tumors and their orthologs are involved in development of progressive traits in humans

Oncogenes, tumor suppressor and differentiation genes represent the oldest human gene classes and evolve concurrently

The increase of the magnitude of spontaneous viral blips in some participants of phase II clinical trial of therapeutic optimized HIV DNA vaccine candidate